How Schwartz was paid
$8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Norman SchwartzChief Executive Officer and Chairman | $1,089,877 | $4,856,574 | $1,458,975 | $562,088 | $28,327 | $7,995,841 |
| Roop K. LakkarajuExecutive Vice President, Chief Financial Officer | $629,100 | $1,618,956 | $387,358 | $334,212 | $21,112 | $2,990,738 |
| Jonathan P. DiVincenzoPresident and Chief Operating Officer | $673,208 | $2,023,696 | $484,122 | $476,702 | $23,044 | $3,680,772 |
| Rajat MehtaExecutive Vice President, Global Commercial Operations | $220,096 | $2,158,707 | — | $270,106 | $31,133 | $2,680,042 |
| James BarryExecutive Vice President, President, Life Science Group | $536,752 | $1,214,217 | $290,493 | $266,079 | $303,685 | $2,611,227 |
What changed and why
- $8MChief Executive Officer Norman Schwartz received total compensation of $7,995,841 in fiscal 2025.
- The ratio of CEO compensation to median employee compensation was 97 to 1.
- 96%Stockholders previously approved the executive compensation program with 96% support in 2023.
- Executive compensation comprises base salary, performance-based cash bonuses, and long-term equity awards.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.